LTB4R2
Basic information
Region (hg38): 14:24305734-24312053
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LTB4R2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 35 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 0 | 3 |
Variants in LTB4R2
This is a list of pathogenic ClinVar variants found in the LTB4R2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24305953-A-G | not specified | Uncertain significance (Mar 29, 2022) | ||
14-24306043-C-T | not specified | Uncertain significance (Jan 16, 2024) | ||
14-24306417-C-T | not specified | Uncertain significance (May 20, 2024) | ||
14-24306463-C-T | not specified | Likely benign (Apr 01, 2024) | ||
14-24306522-G-T | not specified | Uncertain significance (Aug 19, 2023) | ||
14-24307384-T-C | not specified | Uncertain significance (Apr 22, 2022) | ||
14-24307385-C-T | not specified | Uncertain significance (Oct 22, 2021) | ||
14-24307414-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
14-24307415-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
14-24307441-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
14-24307442-G-A | not specified | Uncertain significance (May 01, 2022) | ||
14-24307448-G-T | not specified | Uncertain significance (Jan 16, 2024) | ||
14-24307483-C-T | not specified | Uncertain significance (Feb 06, 2024) | ||
14-24307484-G-A | not specified | Uncertain significance (Apr 12, 2024) | ||
14-24307489-A-G | not specified | Uncertain significance (Oct 05, 2023) | ||
14-24310712-G-C | not specified | Uncertain significance (Nov 18, 2022) | ||
14-24310729-C-T | not specified | Uncertain significance (Dec 07, 2021) | ||
14-24310771-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
14-24310785-G-C | not specified | Uncertain significance (Apr 17, 2024) | ||
14-24310789-T-C | not specified | Uncertain significance (Dec 27, 2022) | ||
14-24310819-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
14-24310819-G-C | not specified | Uncertain significance (Mar 28, 2024) | ||
14-24310834-C-T | not specified | Uncertain significance (May 24, 2024) | ||
14-24310840-C-A | not specified | Uncertain significance (Sep 26, 2023) | ||
14-24310858-C-T | not specified | Uncertain significance (Nov 08, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LTB4R2 | protein_coding | protein_coding | ENST00000543919 | 1 | 6320 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000439 | 0.671 | 125097 | 4 | 534 | 125635 | 0.00214 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.296 | 252 | 239 | 1.05 | 0.0000161 | 2144 |
Missense in Polyphen | 115 | 109.56 | 1.0497 | 1069 | ||
Synonymous | -0.524 | 128 | 121 | 1.06 | 0.00000865 | 871 |
Loss of Function | 0.767 | 6 | 8.40 | 0.714 | 5.00e-7 | 64 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00166 | 0.00160 |
Ashkenazi Jewish | 0.00174 | 0.00169 |
East Asian | 0.0141 | 0.0134 |
Finnish | 0.000495 | 0.000416 |
European (Non-Finnish) | 0.00183 | 0.00170 |
Middle Eastern | 0.0141 | 0.0134 |
South Asian | 0.000602 | 0.000555 |
Other | 0.00206 | 0.00196 |
dbNSFP
Source:
- Function
- FUNCTION: Low-affinity receptor for leukotrienes including leukotriene B4. Mediates chemotaxis of granulocytes and macrophages. The response is mediated via G-proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTB4 > 12-epi-LTB4 > LTB5 > LTB3.;
- Pathway
- Calcium signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);GPCRs, Other;Signaling by GPCR;Signal Transduction;Eicosanoid ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;Leukotriene receptors;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Intolerance Scores
- loftool
- 0.723
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.38
Haploinsufficiency Scores
- pHI
- 0.165
- hipred
- N
- hipred_score
- 0.238
- ghis
- 0.498
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.657
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ltb4r2
- Phenotype
- immune system phenotype; skeleton phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- chemotaxis;inflammatory response;G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;neuropeptide signaling pathway;keratinocyte migration;leukotriene signaling pathway
- Cellular component
- nucleoplasm;plasma membrane;integral component of plasma membrane;membrane
- Molecular function
- leukotriene B4 receptor activity;galanin receptor activity;leukotriene receptor activity;G protein-coupled peptide receptor activity